- From: Kashyap, Vipul <VKASHYAP1@PARTNERS.ORG>
- Date: Thu, 24 Jul 2008 14:22:22 -0400
- To: "John Madden" <john.madden@me.com>, "w3c semweb HCLS" <public-semweb-lifesci@w3.org>, "Chimezie Ogbuji" <ogbujic@ccf.org>
- Cc: "Mary Kennedy" <mkenned@cap.org>, <helen.chen@agfa.com>, "Pathak, Jyotishman, Ph.D." <Pathak.Jyotishman@mayo.edu>, "Rachel Richesson" <Rachel.Richesson@epi.usf.edu>
> I really like your idea of picking a specific subdomain, like drug > terminology, and using that to test out the pitfalls/possibilities. > > (Actually, I think very domain-specific ontolgies have, as a > rule, the > strongest likelihood of short-term practical utility.) I think this is a great suggestion. And more interestingly, the drug ontology mapping work we are doing in the COI task could be a concrete use case for this conversion. http://esw.w3.org/topic/HCLS/ClinicalObservationsInteroperability/DrugMapping.ht ml We can try to integrate various perspectives in this: - E-prescribing - Drug Discovery - Therapeutic Decision Support - Mechanism of Action - ... Cheers, ---Vipul The information transmitted in this electronic communication is intended only for the person or entity to whom it is addressed and may contain confidential and/or privileged material. Any review, retransmission, dissemination or other use of or taking of any action in reliance upon this information by persons or entities other than the intended recipient is prohibited. If you received this information in error, please contact the Compliance HelpLine at 800-856-1983 and properly dispose of this information.
Received on Thursday, 24 July 2008 18:23:05 UTC